CO15 Clinical Outcomes of Patients with Relapsed/Refractory Large B-Cell Lymphoma Receiving Second-Line Therapy in England: A Multicenter, Retrospective, Real-World Study

This study examines the impact of ASCT-eligibility on survival outcomes in R/R LBCL.

Source: Value in Health - December 1, 2023 Category: International Medicine & Public Health Authors: C.P. Fox, F. Toron, E. Tyas, M. Cooper, J. Richards, P. Williams Source Type: research